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The phosphatidylinositol-3-kinase/phosphatase and tensin homolog (PTEN)-mammalian
target of rapamycin (mTOR) pathway regulates a variety of neuronal functions, including
cell proliferation, survival, growth, and plasticity. Dysregulation of the pathway is implicated
in the development of both genetic and acquired epilepsies. Indeed, several causal
mutations have been identiﬁed in patients with epilepsy, the most prominent of these
being mutations in PTEN and tuberous sclerosis complexes 1 and 2 (TSC1, TSC2). These
genes act as negative regulators of mTOR signaling, and mutations lead to hyperactivation
of the pathway. Animal models deleting PTEN, TSC1, and TSC2 consistently produce
epilepsy phenotypes, demonstrating that increased mTOR signaling can provoke neuronal
hyperexcitability. Given the broad range of changes induced by altered mTOR signaling,
however, the mechanisms underlying seizure development in these animals remain
uncertain. In transgenicmice, cell populationswith hyperactivemTOR havemany structural
abnormalities that support recurrent circuit formation, including somatic and dendritic
hypertrophy, aberrant basal dendrites, and enlargement of axon tracts. At the functional
level, mTOR hyperactivation is commonly, but not always, associated with enhanced
synaptic transmission and plasticity. Moreover, these populations of abnormal neurons
can affect the larger network, inducing secondary changes that may explain paradoxical
ﬁndings reported between cell and network functioning in different models or at different
developmental time points. Here, we review the animal literature examining the link
betweenmTOR hyperactivation and epileptogenesis, emphasizing the impact of enhanced
mTOR signaling on neuronal form and function.
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INTRODUCTION
Themammalian target of rapamycin (mTOR) is a serine/threonine
kinase involved in the highly conserved phosphatidylinositol-3-
kinase (PI3K)-Akt signaling pathway. mTOR regulates neuronal
proliferation, survival, growth, and functioning (Sarbassov et al.,
2005). Since this pathway is critical to development, dysregula-
tion at any stage can have deleterious consequences (Tokuda et al.,
2011). Mutations or deletions of phosphatase and tensin homolog
(PTEN) and the heterodimeric complex of tuberous sclerosis pro-
teins 1 and 2 (TSC1/hamartin, TSC2/tuberin) can dramatically
upregulate mTOR signaling and contribute to a class of human
neurological diseases characterized as “TORopathies” (Crino,
2009;Wong andCrino,2012). PTENdysregulationhas been linked
to disorders that include Lhermitte–Duclos disease (Liaw et al.,
1997), Cowden syndrome (Gofﬁn et al., 2001), Proteus syndrome
(Zhou et al., 2001), and Bannayan–Riley–Ruvalcaba syndrome
(Arch et al., 1997; Eng, 2003). Additionally, PTEN mutations
have been associated with a number of neurological conditions,
such as epilepsy, macrocephaly, mental retardation, and autism
spectrum disorders (Marsh et al., 1999; Gofﬁn et al., 2001; Zhou
et al., 2003; Butler et al., 2005; Herman et al., 2007; O’Roak et al.,
2012; Epi4KConsortium and Epilepsy Phenome/Genome Project,
2013). Dysregulation of either TSC1 or TSC2 leads to TSC, a
disorder characterized by the widespread development of non-
malignant tumors in multiple organ systems, including the brain,
eyes, heart, skin, and lungs (for review, see Franz et al., 2010).
However, the central nervous system (CNS) manifestations of
TSC are the most disabling and include seizures, mental retarda-
tion, and behavioral disorders like autism (Sparagana and Roach,
2000). Epilepsy is the most common neurological symptom of
TSC, often developing within a year of birth and affecting 60–
90% of individuals over their lifetime (Holmes and Stafstrom,
2007). Promisingly, the mTOR antagonist rapamycin and its
analogs have already entered clinical trials for TSC, with initial
studies showing encouraging results (Krueger and Franz, 2008;
Muncy et al., 2009; Wong, 2010; Kotulska et al., 2013; Krueger
et al., 2013). TORopathies may also include disorders with evi-
dence of enhanced mTOR signaling, but lacking known mTOR
pathway mutations. For example, enhanced mTOR signaling has
been observed in focal cortical dysplasia (Chen et al., 2012; Lim
and Crino, 2013; Wong, 2013b; Yasin et al., 2013) and mesial tem-
poral sclerosis (Sha et al., 2012; Sosunov et al., 2012); although
the role of enhanced signaling in these conditions remains
uncertain.
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Mammalian target of rapamycin activation is controlled by
the PI3K/Akt signaling pathway, where PTEN and the com-
bined TSC1 and TSC2 complex act as negative regulators
(Figure 1). PI3K is responsible for the production of phos-
phatidylinositol (3,4,5)-triphosphate (PIP3) through the phos-
phorylation of the biphosphate PIP2. PTEN acts in opposition
to PI3K, dephosphorylating PIP3, resulting in the production
of the PIP2. PIP3 binds PDK-1, allowing PDK-1 to acti-
vate Akt; thus, PTEN prevents Akt activation through the
depletion of available PIP3. When Akt is activated it binds
to TSC1/TSC2 complex. Normally when TSC1 and TSC2 are
dimerized, the complex binds to RAS homolog enriched in
brain (RHEB); however, activated Akt phosphorylates TSC2
and prevents RHEB from binding. In this case, GTP-bound
RHEB activates mTOR. Therefore, loss-of-function mutations
or removal of PTEN, which leads to hyperactivation of Akt,
or loss of TSC1/TSC2, which leads to increased unbound
RHEB, can cause an upregulation of mTOR signaling. Fur-
thermore, the mTOR pathway contains two “arms” in which
signaling is mediated either by mTOR complex 1 (mTORC1)
or mTOR complex 2 (mTORC2). mTORC1 signaling requires
activation of the adaptor protein raptor, while mTORC2 sig-
naling requires the rictor adaptor protein. Studies implicate
mTORC1 in regulating cell growth and proliferation(for review,
see Fingar and Blenis, 2004; Magri et al., 2011), while mTORC2
is implicated in regulating the actin cytoskeleton, soma size,
dendritic growth, and dendritic tiling (Jacinto et al., 2004; Koike-
Kumagai et al., 2009; Urbanska et al., 2012; Thomanetz et al.,
2013).
FIGURE 1 | PI3K/PTEN–mTOR pathway. mTOR is activated by signaling
through the PI3K–Akt pathway, regulating cell growth and proliferation.
PTEN, TSC1, andTSC2 act as negative regulators of the mTOR pathway,
and removal leads to hyperactivation of mTOR. mTOR complex 1
(mTORC1) signaling requires activation of the adaptor protein raptor, and
mTOR complex 2 (mTORC2), which is largely insensitive to acute
rapamycin treatment, requires activation of the rictor protein. Although
regulation of mTORC2 is less clearly deﬁned, it has been linked to
cytoskeleton organization.
INVOLVEMENT OF mTOR IN EPILEPTOGENESIS
EPILEPSY IS CHARACTERIZED BY RESTRUCTURING OF NEURONAL
CIRCUITS IN THE BRAIN
It has been known since the 1980s that epilepsy can be associated
with dramatic restructuring of neuronal pathways. Some of the
best evidence of this comes from studies of the hippocampus.
In tissue surgically resected from patients with temporal lobe
epilepsy, hippocampal dentate granule cell mossy ﬁber axons
were found to form de novo projections into the dentate inner
molecular layer (IML) (Sutula et al., 1989). Subsequent stud-
ies revealed that these sprouted axons form excitatory synaptic
connections with granule cell dendrites projecting through the
IML, creating recurrent loops which have been hypothesized to
promote hyperexcitability (for review, see Nadler, 2003). More
recently, studies usingmodels of temporal lobe epilepsy have iden-
tiﬁed ectopic granule cells (Parent et al., 1997; Scharfman et al.,
2000;Overstreet-Wadiche et al., 2006), hypertrophied granule cells
(Suzuki et al., 1995; Murphy et al., 2011, 2012), granule cells with
basal dendrites (Ribak et al., 2000, 2012; Overstreet-Wadiche et al.,
2006; Murphy and Danzer, 2011), and granule cells with altered
synaptic structure (Pierce and Milner, 2001; Danzer et al., 2010;
McAuliffe et al., 2011; Upreti et al., 2012) as common patholo-
gies of the disorder. Interestingly, the dentate gyrus is one of only
two regions exhibiting persistent neurogenesis in adulthood, and a
majority of the granule cells exhibiting these pathological abnor-
malities appear to be newborn (Parent et al., 2006; Walter et al.,
2007; Kron et al., 2010; Santos et al., 2011). Moreover, these post-
seizure born dentate granule cells exhibit acceleratedmaturity and
functional integration into the network; receiving perforant-path
input sooner than in a normal brain (Overstreet-Wadiche et al.,
2006). While the continued generation of neurons in the den-
tate may make the region particularly vulnerable to epileptogenic
rewiring (Jessberger et al., 2007; Danzer, 2008), restructuring of
neuronal circuits is also evident in other brain regions. Rewiring
is evident in cortical epilepsy models (for example, Graber and
Prince, 2004), and histological and functional mapping studies in
humans with a range of epilepsy syndromes support the conclu-
sion that restructuring is a recurring feature of the disease (Bonilha
et al., 2012; Fang et al., 2013;Woodward et al., 2013; Xu et al., 2013;
Haneef et al., 2014). Changes in neuronal circuitry in epilepsy
can be widespread and profound, ranging from alterations in
synaptic protein expression and synaptic strength at the subcel-
lular level, to neuronal loss and addition at the cellular level, to
altered connectivity between brain regions at the systems level.
While such changes are likely to involve many signaling path-
ways, the mTOR pathway stands out for its ability to regulate
cell proliferation, cell survival, cell growth, and synaptic strength.
These features make it an appealing candidate for involvement in
epileptogenesis.
HYPERACTIVATION OF THE mTOR SIGNALING PATHWAY
CONSISTENTLY PRODUCES EPILEPSY IN ANIMAL MODELS
Numerous laboratories have examined the impact of PTEN,TSC1,
or TSC2 deletions in mouse models. Initial studies examining
germline deletions of PTEN (Suzuki et al., 1998; Podsypanina
et al., 1999), TSC1 (Kwiatkowski et al., 2002), or TSC2 demon-
strated that loss of gene function produced early mortality
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(Kobayashi et al., 1999; Onda et al., 1999). CNS deletion using
conditional approaches also reduced survival in mice (Groszer
et al., 2001; Zhou et al., 2009). Therefore, in order to generate
viable animals that could be used to study cellular consequences of
mTOR hyperactivation, smaller neuronal populations have been
targeted withmore speciﬁc Cre-loxP promoters (Kwon et al., 2001;
Marino et al., 2002; Uhlmann et al., 2002; Fraser et al., 2004; Yue
et al., 2005; Erbayat-Altay et al., 2007; Meikle et al., 2007; Wang
et al., 2007; Zeng et al., 2008, 2011; Way et al., 2012), develop-
mentally timed promoters (Kwon et al., 2006; Zhou et al., 2009),
tamoxifen-inducible promoters inwhich gene removal canbe tem-
porally controlled by the researcher (Amiri et al., 2012; Pun et al.,
2012), or a combination of these techniques (Abs et al., 2013). As
illustrated by Figure 2, PTEN removal from dentate granule cells
leads to hyperactivation of mTOR, evident as an increase in phos-
phorylated ribosomal protein S6 (pS6). Rapamycin treatment to
prevent mTOR activation blocks the increase in pS6. Although
many Cre promoters have been utilized to create the different
mouse models, one of the commonalities between these trans-
genic mice is the incidence of seizures. For example, mice with
PTEN removed from 30–60% of mature CA3 neurons, dentate
granule cells, and layer III–V cortical neurons developed sponta-
neous seizures (Kwon et al., 2006), and 40% of mice with PTEN
deleted from subgranular and subventricular zone progenitors
developed spontaneous seizures (Amiri et al., 2012). Work by Pun
et al. (2012) produced the most selective deletion to date, with
PTEN removal from as little as 9% of the dentate granule cell pop-
ulation, producing a profound epilepsy syndrome in almost all
animals. While PTEN is further upstream frommTOR than TSC1
and TSC2, deletion of either of these regulatory proteins produces
similar consequences; although the time course of epileptogenesis
varies betweenmodels. Removal of TSC1 using Synapsin-Cre mice
produced knockout (KO) cells throughout the cortex, subcortical
gray matter, and hippocampal CA3 and hilar neurons. These ani-
mals developed spontaneous seizures by post-natal day 5 and died
between 3 and 5weeks of age (Meikle et al., 2007; Choi et al., 2008).
Removal of TSC1 fromcortical and subventricular zoneneurons in
Emx1-Cre mice was associated with cortical seizures at post-natal
day 13 (Magri et al., 2011; Carson et al., 2012). Similarly,GFAP-Cre
directedTSC1 or TSC2 deletion fromastrocytes and someneurons
(Bajenaru et al., 2002; Su et al., 2004) produced seizures between
3 weeks and 2 months of age (Uhlmann et al., 2002; Erbayat-Altay
et al., 2007; Zeng et al., 2008, 2010, 2011), while mice with TSC1 or
TSC2 removal from radial glial cells commonly had seizures before
their death at 3–4weeks of age (Way et al., 2009;Magri et al., 2013).
Finally, recent work by Abs et al. (2013) produced the intriguing
result that global deletion of TSC1 from adult animals could result
in the onset of spontaneous seizures within 2–9 days. Such rapid
epileptogenesis would favor changes that could occur quickly, such
as altered neuron physiology. Some “leaky” expression from their
Cag-CreERT driver line, however, lead to premature TSC1 dele-
tion from a small number of cells, leaving open the possibility
longer term changes among these TSC1 KO cells may accelerate
epileptogenesis in the animals. Taken together, these data suggest
that mTOR hyperactivation among a wide range of cell types can
drive epileptogenesis.
ENHANCED mTOR SIGNALING IN ACQUIRED EPILEPSY MODELS
Mammalian target of rapamycin pathway upregulation has been
described in several animal models of acquired epilepsy. In
acquired epilepsy models, epileptogenesis is induced by experi-
mentally injuring the brain using, for example, convulsant drugs
or hypoxia. The mTOR pathway is not genetically manipulated
in these models, as is the case for TSC and PTEN mutants, so
changes in mTOR signaling reﬂect physiological responses to the
injury. It is notable, therefore, that hyperactivation of mTOR sig-
naling is present in acute seizure (Zhang and Wong, 2012), status
epilepticus (Okamoto et al., 2010; Macias et al., 2013), traumatic
brain injury (Chen et al., 2007), hypoxia (Talos et al., 2012; Sun
et al., 2013), and in vitro (Berdichevsky et al., 2013) models of
epilepsy. Following traumatic brain injury, phosphorylatedmTOR
was signiﬁcantly increased after 30 min and remained elevated
for 4–24 h (Chen et al., 2007). In the kainic acid status epilepti-
cus model of epilepsy, mTOR signaling increased 1 h after injury,
returned to baseline at 24 h, and increased again beginning at 3
days. This second wave lasted for several weeks (Zeng et al., 2009).
FIGURE 2 | Dentate granule cells lacking PTEN have hyperactive
mTOR signaling. Confocal maximum projections of the dentate gyrus
from control mice, Gli1-CreERT2 × PTENﬂ/ﬂ (PTEN KO) mice, and
rapamycin treated PTEN KO mice immunostained for phosphorylated
ribosomal protein S6 (pS6; red). pS6, the downstream target of mTOR
complex 1, is greatly increased in the dentate granule cell layer (DGC-L)
in the PTEN KO animal, demonstrating the upregulation of mTOR
signaling with the removal of PTEN. Rapamycin treatment, and thus
inhibition of mTOR, prevents the increase in pS6 in PTEN KO mice. Scale
bar = 25 μm. Images courtesy of Isaiah Rolle.
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Persistent upregulation of the pathway is hypothesized to initiate
changes in neuronal structure and physiology that contribute to
epileptogenesis. Consistent with this idea, administration of the
mTORantagonist rapamycin has been found to inhibitmossy ﬁber
sprouting and mitigate the development of spontaneous seizures
in several models of epilepsy (for review, see Wong, 2013a). On
the other hand, work by Buckmaster and colleagues found that
rapamycin was ineffective at reducing spontaneous seizure fre-
quency in mice (Buckmaster and Lew, 2011; Heng et al., 2013);
although mossy ﬁber sprouting was still blocked (Buckmaster
et al., 2009). Whether the discrepant results reﬂect species dif-
ferences (mouse vs. rat), model differences, or other factors is not
known. Nonetheless, the subset of positive animal ﬁndings, com-
bined with promising clinical data in children with TSC (Krueger
and Franz, 2008; Muncy et al., 2009; Wong, 2010; Kotulska et al.,
2013; Krueger et al., 2013), provide a strong rationale for further
investigations.
REGULATION OF NEURONAL FORM AND FUNCTION BY mTOR
Given the extensive literature demonstrating neuronal rewiring
in epilepsy, the ability of mTOR hyperactivation in the CNS
to cause epilepsy, the evidence that the mTOR pathway is acti-
vated during epileptogenesis, and the role played by mTOR
signaling in regulating neuronal plasticity, we decided to
explore the consequences of enhanced mTOR signaling on neu-
ronal form and function in the second part of this review.
While the exact mechanisms by which excess mTOR signaling
promotes epilepsy remain uncertain, we believe that under-
standing the cellular impacts of this signaling provides novel
insights.
CELL PROLIFERATION
The mTOR signaling pathway is an important regulator of devel-
opmental and adult neurogenesis. Cell proliferation is impaired
in mTOR KO mice, as well as RAPTOR and RICTOR KO mice,
in which mTORC1 or mTORC2 signaling, respectively, is blocked.
Loss of either mTOR, raptor, or rictor results in embryonic lethal-
ity, possibly in part due to impaired cell proliferation (Gangloff
et al., 2004; Murakami et al., 2004; Guertin et al., 2006; Shiota
et al., 2006; Cloetta et al., 2013). Conversely, embryonic deletion
of PTEN from CNS stem/progenitor cells decreases apoptosis
and increases neuron numbers compared to controls (Groszer
et al., 2001). TSC deletions also promote cell proliferation, with
the hallmark feature of the human disease being cortical tubers.
The tubers are accumulations of non-malignant cells that exhibit
abnormal proliferation, differentiation, and migration. In devel-
oping animals, TSC1 deletion from radial glial cells disrupts the
subventricular proliferative zones and leads to megalencephaly
(Magri et al., 2013). In the adult brain, effects of mTOR dysregu-
lation on neuronal proliferation are less pronounced since adult
neurogenesis is limited to olfactory and hippocampal granule neu-
rons, but it is clear thatmTORplays an important role in regulating
the generation of these cells (Hartman et al., 2013;Magri andGalli,
2013). Conditional deletion of PTEN from the subventricular zone
progenitors, for example, increased proliferation of neurons pop-
ulating the olfactory bulb (Gregorian et al., 2009), while inhibiting
the PI3K/PTEN–mTOR pathway (using rapamycin and the PI3K
inhibitor LY294002) led to reduced subventricular zone prolifer-
ation (Peltier et al., 2007; Paliouras et al., 2012). Rapamycin had
a similar effect on subgranular zone production of granule cells
(Raman et al., 2013). These data suggest that proliferation of adult-
generated dentate granule cells would be increased with mTOR
hyperactivation due to PTEN, TSC1, or TSC2 deletion. Consistent
with this, investigators examining PTEN KO mice, including the
GFAP-Cre and Nestin-CreERT2 lines, have reported increased cell
proliferation in vivo at early time points (up to 4 months; Fraser
et al., 2004; Amiri et al., 2012). However, increased production of
granule cells may be temporary, as proliferation rates declined at
later time points (Amiri et al., 2012). It is possible that the acceler-
ated differentiation, which contributes to increased proliferation
at early time points, depletes the subgranular zone stem cell pool
at later time points. Ventricular zone progenitors, on the other
hand, do not appear to exhibit the same limitation (Gregorian
et al., 2009).
Increased neurogenesis from enhanced mTOR signaling can
have profound effects when the altered signaling occurs early in
development and is widespread, with the excess neurons con-
tributing to gross brain abnormalities like hemimegalencephaly.
Altered neurogenesis may also contribute to more subtle defects,
like heterotopias and dysplasias. These small clusters of abnormal
neurons often develop into epileptic foci, as evidenced by elec-
troencephalography (EEG) studies and the abolition of seizures
in many patients following surgical removal of the abnormal cells
(for review, see Hauptman and Mathern, 2012). Interestingly, evi-
dence has recently emerged suggesting that prenatal infection with
human papillomavirus (HPV)may disruptmTOR signaling, lead-
ing to the development of focal cortical dysplasia type II. TheHPV
oncoprotein E6 was found in resected human dysplasias, but not
surrounding tissue, and transfection of fetal mouse brain with
an E6 expression vector potently activated mTOR targets (Chen
et al., 2012; Lim and Crino, 2013;Wong, 2013b; Yasin et al., 2013).
Additional subtle effects of increased mTOR signaling in acquired
epilepsymay include the burst of neurogenesis observed following
epileptogenic brain injury in rodents (Parent et al., 1997). mTOR
signaling promotes neurogenesis, and large numbers of these new-
born cells integrate abnormally, raising the possibility that these
new neurons may by epileptogenic (Scharfman and Hen, 2007;
Scharfman and McCloskey, 2009; Parent and Kron, 2012). If true,
it is possible that reduced seizure frequency followingmTOR inhi-
bition (for review, see Ryther and Wong, 2012) may be partly
mediated by reduced neurogenesis. Finally, evidence that sub-
granular zone progenitors can be depleted following prolonged
mTOR hyperactivation raises the possibility that epileptogenesis
and seizures could accelerate the decline of this important cell
population (Amiri et al., 2012). In some rodent epilepsy models,
granule cell neurogenesis is increased in the ﬁrst few weeks and
months after the insult, but persistent decreases in neurogenesis
have been observed when the animals are examined months later
(Hattiangady and Shetty, 2010; Danzer, 2012).
SOMATIC HYPERTROPHY
Somatic hypertrophy among neurons has been one of the
most consistent ﬁndings in cells with increased mTOR signal-
ing (Figure 3). In animal models, somatic hypertrophy has been
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FIGURE 3 | Dentate granule cells lacking PTEN exhibit structural
abnormalities. Confocal maximum projections of control and Gli1-
CreERT2 × PTENﬂ/ﬂ (PTEN KO) granule cells, ﬁlled with biotin and labeled
with Alexa-Fluor 594-conjugated streptavidin. The PTEN KO cell exhibits
somatic hypertrophy and dramatically increased dendritic thickness compared
to the control dentate granule cell. Additionally, basal dendrites are commonly
found on the PTEN-negative cells, here indicated by blue arrows.White
arrowheads highlight the mossy ﬁber axon extending toward the hilus from
each of the two cells. Scale bar = 50 μm. Images courtesy of Victor R. Santos
and Dr. RaymundY. K. Pun.
observed following deletion of TSC1 (Meikle et al., 2007; Zeng
et al., 2008; Zhou et al., 2009; Tsai et al., 2012), TSC2 (Zeng
et al., 2011; Tsai et al., 2014), and PTEN (Backman et al., 2001;
Groszer et al., 2001; Kwon et al., 2001, 2003, 2006; Fraser et al.,
2004; Ljungberg et al., 2009; Amiri et al., 2012; Pun et al., 2012).
Hypertrophy has been detected in hippocampal granule cells
(Backman et al., 2001; Kwon et al., 2001, 2003, 2006; Fraser et al.,
2004; Amiri et al., 2012; Pun et al., 2012), cortical neurons (Fraser
et al., 2004; Kwon et al., 2006; Meikle et al., 2007; Ljungberg et al.,
2009; Zhou et al., 2009), and purkinje cells (Tsai et al., 2012;
Thomanetz et al., 2013). Treatment with rapamycin or CCI-779
to inactivate mTOR prevents the somatic hypertrophy (Kwon
et al., 2003; Zeng et al., 2008, 2011; Zhou et al., 2009), and sim-
ilarly, inhibition of mTORC2 signaling by deletion of RICTOR
reduces neuronal size (Thomanetz et al., 2013). Somatic enlarge-
ment associated with mTOR hyperactivation is seen in human
TORopathies, and is particularly prominent in patients with TSC,
who exhibit giant cells within the tubers that characterize the
disease (White et al., 2001). Enlarged neurons are also present
in focal cortical dysplasia, in which cytomegalic neurons and
“balloon cells” are characteristic. Altogether, these data support
the conclusion that mTOR dysregulation promotes abnormal cell
growth.
Increased soma size can alter neuronal function at both micro-
scopic and macroscopic levels. At the single cell level, increased
soma area would be predicted to decrease cellular input resistance
and increase total cell capacitance. These predictions were upheld
by Luikart et al. (2011) in work examining hippocampal gran-
ule cells following small hairpin RNA (shRNA)-mediated PTEN
knockdown. Knockdown cells exhibited neuronal hypertrophy,
decreased input resistance, and increased capacitance. Similar
ﬁndings were reported for TSC1 KO cells (Bateup et al., 2011,
2013b). At the macroscopic level, increased soma size in PTEN,
TSC1, or TSC2 KO mice contributes to gross distortion of brain
structure. Speciﬁcally, cellular hypertrophy (potentially combined
with increased neurogenesis) leads to progressive macrocephaly
with increased brain size in mouse models, usually accompanied
by disorganization of cell layers (Groszer et al., 2001; Kwon et al.,
2001, 2003, 2006; Fraser et al., 2004; Zeng et al., 2008, 2011; Zhou
et al., 2009;Amiri et al., 2012). The increase in cell size and cell layer
disorganization can cause compression of other brain areas, such
as hippocampalCA1 in theNSE-Cre PTENKOmouse (Kwon et al.,
2006). These dramatic disruptions likely contribute to functional
deﬁcits in the animal models and humans with related conditions
like hemimegalencephaly.
CELL POLARIZATION
Establishing proper polarity is critical step in neuronal differen-
tiation, and mTOR signaling appears to play a modulatory role
in this process. In the rodent hippocampal dentate gyrus, granule
cells typically possess only apical dendrites, which extend from
the soma into the dentate molecular layer. When the mTOR path-
way is hyperactivated in granule cells by PTEN deletion, however,
large numbers of granule cells develop aberrant basal dendrites
(Figure 3; Kwon et al., 2006; Pun et al., 2012). Basal dendrites
are also a feature of rodent epilepsy models, where the abnormal
processes project into the dentate hilus. These hilar-projecting
dendrites are innervated by the mossy ﬁber axons of neighboring
granule cells, creating recurrent excitatory loops which may con-
tribute to hyperexcitability (Ribak et al., 2000, 2012; Thind et al.,
2008). Granule cell basal dendrites that develop after PTEN dele-
tion have spines apposed to presynaptic terminals of mossy ﬁber
axons, suggesting they alsomediate the formation of recurrent cir-
cuits (Pun et al., 2012). These recurrent connections are thought
to contribute to hyperexcitability and seizure generation in PTEN
KO animals.
Whether PTEN deletion disrupts cell polarization directly or
indirectly is not clear. Immature granule cells frequently exhibit
transient basal dendrites, which are eliminated as the cells mature
(for review, see Rahimi and Claiborne, 2007). Retraction of
these basal dendrites appears to be regulated by activity, since
increasing neuronal activity in vitro can lead to their persis-
tence (Nakahara et al., 2009). It is possible, therefore, that basal
dendrites in PTEN KO mice are a consequence of increased
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neuronal activity in these animals (or the seizures that ultimately
develop), although additional studies will be needed to test the
idea.
AXON GROWTH
Axon growth appears to be promoted by the mTOR pathway, and
disrupted mTOR activation can lead to irregular axon develop-
ment. Overexpression of TSC1 or 2 in vitro – thus decreasing
mTOR signaling – results in fewer neurons possessing an axon.
Conversely, KO of TSC1 or knockdown of TSC2 increases the
number of neuronswithmultiple axons (Figure 4), and rapamycin
treatmentwas found tomitigate this effect in theTSC2knockdown
cells (Choi et al., 2008). Consistent with this in vitro work, dele-
tion of TSC1 in a Synapsin-Cre TSC1 KO mouse model led to
ectopic axon growth in cortex (Choi et al., 2008). PTEN removal
in vivo also increased axon growth. PTEN deletion from den-
tate granule cells, occurring during development or after the cells
mature, led to progressive enlargement of the granule cell mossy
ﬁber axon tract (Kwon et al., 2006; Amiri et al., 2012). Moreover,
NSE-Cre TSC1KOmice exhibited increased thickness of themossy
ﬁber tract,while rapamycin administration reduced tract thickness
(Zhou et al., 2009). Finally,work byPun et al. (2012) demonstrated
that selective deletion of PTEN from granule cells provoked aber-
rant axon sprouting into the dentate IML (mossy ﬁber sprouting,
Figure 5). Together, these data suggest that mTOR signaling is
involved in axon outgrowth, and disruption of this pathway can
lead to axon path thickening (presumably due to larger numbers
of axons/axon collaterals).
The mechanism by which mTOR signaling promotes the
sprouting of granule cell mossy ﬁber axons into the dentate IML
remains unclear. In acquired epilepsy models, rapamycin has been
consistently found to block mossy ﬁber sprouting, suggesting that
increased mTOR signaling may mediate this pathology directly
(Zeng et al., 2009; Huang et al., 2010; Buckmaster andWen, 2011).
However, deletion of PTEN from dentate granule cells does not
always produce mossy ﬁber sprouting. In fact, mossy ﬁber sprout-
ing was only detected in Gli-CreERT2 PTEN KO mice when the
number of granule cells without PTEN exceeded ≈15% of the
entire granule cell population (Pun et al., 2012). Interestingly,
some animals with fewer PTEN KO cells developed seizures, but
not mossy ﬁber sprouting: evidenced both by a lack of mossy ﬁber
terminal immunolabeling in the IML, and an absence of green
ﬂuorescent protein (GFP)-labeled PTEN KO cells axons in this
same region (Pun et al., 2012). These latter ﬁndings suggest that
mossy ﬁber sprouting is an emergent property of mTOR hyper-
activation. Restated, it would appear than mTOR hyperactivation
in individual granule cells is not sufﬁcient to drive mossy ﬁber
sprouting, but large numbers of PTEN KO granule cells acting
together do produce mossy ﬁber sprouting, suggesting that sec-
ondary processes are involved. It has been proposed that mossy
ﬁber sprouting is triggered by mossy cell loss, as the degree of
sprouting is positively correlated with the extent of mossy cell
loss (Jiao and Nadler, 2007). Mossy cell loss in the absence of
seizures, however, does not cause mossy ﬁber sprouting (Jinde
et al., 2012), suggesting that while the two phenomena are corre-
lated, they may not be causally linked. The ability of rapamycin
to block mossy ﬁber sprouting in acquired epilepsy models, and
the apparent inability of increased mTOR signaling to drive
mossy ﬁber sprouting unless a threshold level of KO cells is met,
raises interesting questions about when and where rapamycin is
acting.
The net effect of increased axon sprouting following increased
mTORactivation is uncertain (Buckmaster,2012). Although gran-
ule cell mossy ﬁber sprouting is not required to produce epilepsy
in mTOR hyperactivation models, increased sprouting of gran-
ule cells may contribute to epilepsy progression in the animals by
promoting the formation of recurrent excitatory circuits. Alter-
natively, mossy ﬁber sprouting may play a compensatory role by
promoting feedback inhibition. In addition to contacting excita-
tory granule cells, sprouted mossy ﬁbers have also been observed
FIGURE 4 | Tuberous sclerosis complex deficiency induces multiple
axons in culture. Knockdown of Tsc2 by shRNA (shTsc2) or knockout of
Tsc1 (Cre) induced multiple axons in vitro. (A) E18 rat hippocampal
neurons transfected with either enhanced green ﬂuorescent protein
(EGFP) alone or EGFP together with Tsc2 shRNA. Tsc2 knockdown
induced multiple axons, all of which are positive for Tau1. (B) E17 mouse
hippocampal neurons from Tsc1lox/ﬂox embryos transfected with EGFP
alone or EGFP together with Cre. Arrowheads indicate axons positive for
Tau1. Scale bars = 20 μm. Reprinted with permission from Choi et al.
(2008).
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FIGURE 5 | Mossy fiber sprouting is present in mice with PTEN
removal from dentate granule cells. Confocal maximum projections
of hippocampi from tamoxifen-treated control and Gli1-CreERT2 ×
PTENﬂ/ﬂ (PTEN KO) mice immunostained for GFP (red) and zinc-
transporter 3 ZnT3 (cyan) are shown. ZnT3-labeling reveals the normal
dentate granule cell mossy ﬁber axon terminal ﬁeld (hilus and stratum
lucidum) in the control animal, while mossy ﬁber sprouting into the
dentate granule cell layer (DGC-L) and inner molecular layer (IML) is
evident in the knockout animal (green boxes in the top row correspond
to high resolution images shown in the bottom row). Scale bars =
200 μm (top row) and 30 μm (bottom row). Reprinted with permission
from Pun et al. (2012).
to innervate inhibitory interneurons in animal models of epilepsy
(Frotscher et al., 2006; Sloviter et al., 2006). Enhanced mTOR
signaling may also increase inhibition by promoting sprout-
ing of other neuronal types. Work by Buckmaster and Wen
(2011) demonstrated that inhibiting mTOR with rapamycin in
the pilocarpine model of epilepsy can reduce axon sprouting of
somatostatin-expressingGABAergic interneurons, raising the pos-
sibility that mTOR-mediated sprouting in epilepsy may exert both
pro-excitatory and homeostatic effects, depending on the cell type
affected.
DENDRITIC GROWTH
Signaling through the PI3K/PTEN–mTOR pathway promotes
dendritic growth and branching. In cultured hippocampal neu-
rons, constitutively activating PI3K, or RNA interference (RNAi)
knockdown of PTEN, resulted in increased dendrite number,
branching complexity, and total dendrite length (Jaworski et al.,
2005). Moreover, the effects appear to be mediated by mTOR,
as rapamycin administration blocked abnormal dendritic growth
following constitutive PI3K activation and PTEN knockdown
(Jaworski et al., 2005). In vitro, the effects of PI3K activation on
dendritic length and complexity appear to be limited to imma-
ture neurons, since mature neurons did not exhibit changes in
dendritic structure (Cuesto et al., 2011). Removal of PTEN in
vivo supports in vitro data; PTEN removal from dentate gran-
ule cells resulted in dendritic hypertrophy, elongated dendrites,
and increased arborization among developing neurons (Figure 3;
Kwon et al., 2006; Amiri et al., 2012; Pun et al., 2012). Removal
of TSC1 from dentate granule cells increased molecular layer
thickness, suggesting dendritic hypertrophy akin to the PTEN
KO mice (Zhou et al., 2009). Rapamycin can reduce dendritic
overgrowth in PTEN KO mice, further specifying mTOR signal-
ing in dendritic size and branching (Zhou et al., 2009). Thus, it
appears thatmTORcontrols growthof the somaandneuronal pro-
cesses, and continued activation causes processes to thicken and
elongate.
The structure of the dendritic tree is thought to be critical
for precise signal processing. Therefore, changes in dendritic
thickness associated with mTOR hyperactivation have the poten-
tial to alter synaptic potential integration. Theoretical models
of synaptic potential attenuation use dendrite diameter in the
estimation of the current ﬂow. Thicker dendrites facilitate sig-
nal spread toward the soma compared to thinner dendrites,
although thicker dendrites would also predict smaller excitatory
post-synaptic potentials (EPSPs), as the larger processes should
have lower input resistance (for review, see Rall, 2011). The
increased surface area provided by larger dendrites increases the
post-synaptic “real estate” available for innervation, potentially
constituting one mechanism by which neurons regulate their
synaptic input. Elucidating the net effect of thicker dendrites
will require additional studies, and might vary by neuron and
condition.
CELL INTRINSIC EFFECTS, PRIMARY NETWORK EFFECTS, AND
SECONDARY NETWORK EFFECTS
Anatomical and physiological studies examining the impact of
mTOR hyperactivation following PTEN or TSC deletion have
produced a number of conﬂicting ﬁndings. Some of these dis-
crepancies likely involve the usual suspects, such as cell and
gene-speciﬁc effects, but an emerging story suggests much of
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this complexity may reﬂect a role for the mTOR pathway in
regulating network homeostasis and plasticity. The ability of
mTOR to regulate synaptic structure and function clearly places
the pathway in a position to impact how neurons respond to
activity levels in their environment. This observation has two
important implications. Firstly, it suggests that cells with dis-
rupted mTOR signaling may respond inappropriately to input
from other neurons in a fashion that is context dependent.
Restated, different environments may produce different types of
changes in PTEN or TSC KO cells. Secondly, since PTEN and
TSC KO cells exhibit altered activity patterns, they can inﬂu-
ence the activity of surrounding neurons, and these activity
changes in the network may in turn alter the behavior of the
KO cells (Figure 6). If correct, it may be more useful to view
the mTOR signaling pathway as a means by which a neuron
regulates its “social” behavior in a network. In the following
sections we will present examples that demonstrate typical cell
and gene-speciﬁc differences that account for variability, andmore
FIGURE 6 | Cell-intrinsic effects of altered mTOR signaling and
network influence. In addition to cell-intrinsic effects from disrupted
mTOR signaling in cells lacking PTEN, TSC1, or TSC2 (red “KO” cells),
these cells may respond inappropriately to surrounding wild type (WT) cells
and/or causeWT cells to behave abnormally. These altered dynamics may
produce an abnormal network, facilitating epileptogenesis.
intriguing evidence of primary and secondary network effects on
KO cell behavior.
CELL TYPE AND GENE-SPECIFIC EFFECTS: LONG-TERM DEPRESSION
In addition to changes in cell structure, mTOR hyperactivation
is associated with changes in synaptic plasticity. Physiological
changes that have been detected include a decrease in long-term
depression (LTD). LTD is deﬁned by a reduction in the efﬁcacy of a
synapse and is typically induced experimentally by low frequency
stimulation. Two mechanistically distinct types of LTD co-exist
at hippocampal synapses: a metabotropic glutamate receptor
(mGluR)-dependent form and a N-methyl-D-aspartate (NMDA)
receptor (NMDAR) dependent form (Mulkey and Malenka, 1992;
Bolshakov and Siegelbaum, 1994; Oliet et al., 1997). mGluR-
LTD, which requires dendritic protein synthesis, can be selectively
induced by (S)-3,5-dihydroxyphenylglycine (DHPG), an agonist
that activates group I mGluRs (Palmer et al., 1997; Fitzjohn et al.,
1999; Schnabel et al., 1999; Huber et al., 2001). Activation of group
I mGluRs triggers the PI3K–Akt–mTOR signaling cascade, which
increases Akt and mTOR phosphorylation in CA1 dendrites.
Moreover, treatment with rapamycin or PI3K inhibitors block
DHPG-induced LTD (Hou and Klann, 2004), clearly implicating
mTORsignaling in theprocess. Paradoxically, hyperactivation, like
inhibition, ofmTORseems tomostly impair LTD;possibly as a sec-
ondary consequence of seizures in the animals (Kirschstein et al.,
2007). The targeted cell type also appears to be important. Specif-
ically, Takeuchi et al. (2013) showed mGluR-LTD was impaired
at all ages in PTEN KO mice at the perforant path >> granule
cell synapse, but not CA3 >> CA1 synapses. Interestingly, PTEN
was deleted from dentate granule cells in these animals, whereas
the PTEN gene was left intact in CA1 pyramidal cells, suggest-
ing that mTOR hyperactivation in the post-synaptic cell may be
responsible for the impairment in mGluR-LTD. Supporting this
conclusion, TSC1 deletion speciﬁcally in CA1 neurons did impair
mGluR-LTD in these same cells (Bateup et al., 2011). The loca-
tion of mTOR hyperactivation, therefore, can be an important
modulator of effect.
Interestingly, although PTEN is best known for its ability to reg-
ulate mTOR signaling, some of its effects on LTD may be mTOR
independent. PTEN is required for the expression of NMDAR-
LTD (Wang et al., 2006; Jurado et al., 2010), but TSC1 does not
appear to be important for this form of LTD. Speciﬁcally, Sperow
et al. (2012) foundNMDAR-LTD to be substantially reduced at the
CA3 >> CA1 synapse when PTEN deletion was targeted to post-
synaptic CA1 neurons, while Bateup et al. (2011) demonstrated
that NMDAR-dependent LTD was normal in mice in which TSC1
was deleted fromCA1 neurons. Bothmousemodels exhibit hyper-
activation of mTOR. PTEN, however, is much further upstream
in the mTOR signaling pathway, with potentially distinct conse-
quences. In fact, Jurado et al. (2010) demonstrated the NMDAR
activation triggers an association between PTEN and the synaptic
scaffold, anchoring PTEN at the post-synaptic terminal. Further-
more, PTEN removal, and not TSC1 deletion, would affect the
PIP3 and PI3K inﬂuenced pathways. PI3Kγ is critical forNMDAR-
LTD, and it is thought to signal via the activation of p38 MAPK
and not the mTOR pathway, potentially explaining why NMDAR-
LTD is normal in TSC1 KO mice and impaired in PTEN KO
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mice (Kim et al., 2011). mTOR hyperactivation by TSC1 deletion
likely facilitates changes in network dynamics through the loss
of mGluR-LTD; however, it appears that PTEN deletion would
have more serious consequences for a neuron and its network due
to impairments in both mGluR-LTD and NMDAR-LTD. Gene
speciﬁc effects, therefore, are likely to account for some of the
controversy in the mTOR ﬁeld.
CELL INTRINSIC vs. SECONDARY EFFECTS: DENDRITIC SPINES
Dendritic spines are themajor points of excitatory contact between
neurons, and measures of spine density are frequently used as
an indirect measure of excitatory input. Notably, inhibitory neu-
ron synapses typically form on dendritic shafts or somata, and
therefore are not revealed by light microscopy approaches. Stud-
ies examining mTOR regulation of dendritic spines and synapses
support a pro-excitatory role for the signaling pathway; although
complex mechanisms may be involved. PTEN deletion has been
associated with an increase in spine density in most studies (Kwon
et al., 2006; Pun et al., 2012), however, Haws et al. (2014) recently
observedno change in spine density followingPTENdeletion from
hippocampal granule cells, and actually observed a decrease in
spine density following PTEN knockdown in basolateral amyg-
dala. Despite the reduction in spine density, the changes were
associated with an increase in miniature EPSC (mEPSC) fre-
quency and amplitude (Haws et al., 2014). The authors suggest
that the discrepancy reﬂects a shift from thin spines to mushroom
spines, the latter being associated with stronger synapses. Sim-
ilarly, Luikart et al. (2011) found that PTEN knockdown using
shRNA injection in mice caused increased mEPSCs and sponta-
neous post-synaptic currents in dentate granule cells. Deletion
of TSC1 and TSC2 has been shown to reduce dendritic spine
density among cortical neurons in vivo (Tavazoie et al., 2005;
Meikle et al., 2008) and hippocampal pyramidal cells in organ-
otypic explant cultures (Tavazoie et al., 2005; Meikle et al., 2008);
Since both TSC and PTEN KO mice develop epilepsy, however,
many of the changes observed in these animals likely reﬂect phe-
nomena secondary to the occurrence of increased activity and
spontaneous seizures (Wong and Guo, 2013). Indeed, it is well
established that seizures alone can induce spine loss (Swann et al.,
2000; Brewster et al., 2013; Singh et al., 2013), perhaps account-
ing for the cortical spine loss observed by Meikle et al. (2008)
in TSC1 KO mice. Consistent with this idea, when Bateup et al.
(2011) induced sparse TSC1 deletion from CA1 pyramidal cells
in vivo, which did not induce epilepsy, spine reductions were
absent.
CELL INTRINSIC vs. SECONDARY EFFECTS: BASAL SYNAPTIC
TRANSMISSION
At entorhinal cortex >> dentate granule cell synapses, basal
synaptic transmission has been found to exhibit complex tem-
poral changes in Nse-Cre PTEN KO mice, strongly suggesting
that secondary changes are having a signiﬁcant impact on physi-
ology in these animals. The Nse-Cre transgene produces robust
PTEN deletion from dentate granule cells and CA3 pyrami-
dal cells, with relative sparing of CA1 (Takeuchi et al., 2013).
In young Nse-Cre PTEN KO mice, perforant path stimulation
to evoke EPSCs in the dentate gyrus produced input/output
relationships that were indistinguishable from controls. Middle-
aged animals, on the other hand, exhibited enhanced input/output
relationships (Kwon et al., 2006; Takeuchi et al., 2013). As the
animals aged, however, the differences resolved, with responses
again becoming indistinguishable from controls. Although the
mechanism is uncertain, the return to baseline may reﬂect com-
pensatory modiﬁcations to the network (Takeuchi et al., 2013).
The temporal dynamics of the physiological changes parallel
morphological changes in these animals, with young animals
appearing relatively normal, middle aged animal beginning to
show subtle changes in structure such as increased spine den-
sity, and older animals exhibiting gross structural changes and
seizures.
CELL INTRINSIC vs. SECONDARY EFFECTS: LONG-TERM POTENTIATION
Long-term potentiation (LTP) is considered to be one of the cel-
lular mechanisms that underlies learning. During LTP, synaptic
strength is increased between connected neurons, and is typi-
cally induced by high frequency stimulation. mTOR activation
appears to be involved in late phase LTP (L-LTP), which is long-
lasting and dependent on protein synthesis and gene transcription,
but not in early phase LTP, which is short-lasting and requires
activation of protein kinase C. Inhibiting mTOR with rapamycin
has consistently been shown to decrease L-LTP (Terashima et al.,
2000; Tang et al., 2002; Cammalleri et al., 2003; Cracco et al., 2005;
Tsokas et al., 2005; Vickers et al., 2005; Stoica et al., 2011) and a
recent study of CamKIIα-Cre Rictor KO mice found a similar
L-LTP deﬁcit, implicatingmTORC2 (Huang et al., 2013). Paradox-
ically, although inhibition of mTOR blocks L-LTP, the majority of
studies examining PTEN and TSC KO mice have not found that
hyperactivation of mTOR facilitates it. For example, L-LTP was
decreased in both GFAP-Cre and CamKIIα-Cre PTEN KO mice
(Fraser et al., 2008; Sperow et al., 2012), and TSC1 KOmice exhib-
ited a similar phenotype (Zeng et al., 2007; Abs et al., 2013). These
discordant results, however, may be explained by the occurrence
of seizures in the animals. Seizure activity has been shown to
impair LTP by shifting the majority of synapses to the “poten-
tiated” state, precluding further enhancement (Beck et al., 2000;
Goussakov et al., 2000; Meador, 2007). Consistent with this idea,
Zeng et al. (2007) were able to partially reverse the LTP deﬁcit
in their TSC1 KO mice by applying the NMDA antagonist APV,
suggesting that excessive activation of NMDARs contributes to
this impairment. The study from Takeuchi et al. (2013), in which
Nse-Cre PTEN KO mice were examined at multiple time points,
provides further support for the idea that LTP impairment may
be a secondary effect of mTOR hyperactivation. Similar to the
prior studies, in middle-aged animals, PI3K-dependent LTP was
impaired at perforant path >> dentate granule cells synapses and
Schaffer collateral >> CA1 synapses (Takeuchi et al., 2013). In
contrast to the prior studies, however, when young animals were
examined, they were found to have elevated LTP at perforant
path >> dentate granule cell synapses. A pre-seizure increase
in neuronal excitability of CA1 pyramidal cells and a reduced
threshold for L-LTP in the Schaffer collateral pathway has also
been noted in TSC1 KO mice following an acute deletion (Abs
et al., 2013). Enhanced LTP, therefore, may be a primary effect of
increased mTOR activation, while LTP impairments may reﬂect
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the consequences of secondary phenomena, such as seizures or
structural abnormalities that alter network properties and KO cell
behavior.
CELL INTRINSIC vs. PRIMARY NETWORK EFFECTS
Approaches in which PTEN or TSC deletion is sparsely induced
in neuronal populations have signiﬁcant advantages over more
widespread deletions, as secondary changes, such as seizures,
can be avoided. A “sparse deletion” approach was used by Saba-
tini’s group in an elegant series of papers in which TSC1 was
deleted from brain and tissue of TSC1ﬂox/ﬂox mice using a Cre-
expressing virus. In the ﬁrst study, TSC1 was deleted from
pyramidal cells in organotypic hippocampal explant cultures
(Tavazoie et al., 2005). TSC1 KO cells in this tissue exhibited
increased spine length and spine head width, decreased spine den-
sity and increasedmEPSC amplitude with no change in frequency.
In the follow-up study, a similar approach was used in vivo, but
with very different results (Bateup et al., 2011). Pyramidal cells
in this study did not exhibit any changes in spine morphology
or density, mEPSC amplitude was unchanged, and mEPSC fre-
quency was increased. Interestingly, mGluR-LTD was impaired,
removing an important mechanism for mitigating excess exci-
tation from TSC1 KO cells. Organotypic hippocampal cultures
exhibit much higher activity levels than hippocampus in vivo,
and develop seizure-like activity over time (Dyhrfjeld-Johnsen
et al., 2010). TSC1 KO cells in vitro, therefore, experience a
very different environment than similar KO cells in vivo, poten-
tially explaining the contrasting behavior of the two populations.
Consistent with this idea, Bateup et al. (2013a) were able to
demonstrate in dissociated cultures of TSC1 KO neurons that
pharmacologically blocking activity prevented many of the gene
expression changes in these cells, suggesting that they occur sec-
ondarily to the increased activity levels evident in the TSC1 KO
cultures.
While the majority of studies examining mTOR effects on neu-
ronal function have examined excitatory signaling, it is important
not to downplay the potential signiﬁcance changes in inhibitory
signaling might have. As a case in point, Bateup et al. (2013b)
recently demonstrated that although isolated TSC1 KO CA1 pyra-
midal cells exhibit enhanced mEPSC frequency and impaired
mGluR-LTD in vivo, the KO cells were intrinsically less excitable,
leading to little net change in excitatory synaptic drive. Rather,
they found that network hyperexcitability was likely produced by
a signiﬁcant reduction in inhibitory drive. TSC1 KO cells in these
animals exhibited decreased frequency and amplitude of minia-
ture inhibitory post-synaptic currents (mIPSCs) and reduced
amplitude of evoked IPSCs. These effects could be blocked with
rapamycin treatment, conﬁrming that they aremediated bymTOR
(Bateup et al., 2013b). Altered excitatory/inhibitory balance in the
brain, in this case favoring increased excitability via reduced inhi-
bition, might be an important mechanism by which changes in
mTOR signaling promote epileptogenesis.
SUMMARY
Hyperactivation of the mTOR pathway produces a constellation
of changes predicted to promote epileptogenesis and hyperex-
citability. mTOR signaling can promote adult neurogenesis in the
hippocampus, and many of these new cells can integrate abnor-
mally. Increased neurogenesis occurs in most animal models of
temporal lobe epilepsy and is suspected of contributing to epilep-
togenesis (Jung et al., 2004, 2006; Hester and Danzer, 2013). In
transgenic mice with inactivation or removal of PTEN, TSC1, or
TSC2, cell populations with the resulting mTOR hyperactivation
have many common structural abnormalities, including somatic
and dendritic hypertrophy, aberrant basal dendrites, and enlarge-
ment of axon tracts. Morphological changes are consistent with
increased synaptogenesis and recurrent circuit formation – both
changes predicted to be epileptogenic. At the synaptic level, trans-
genic mouse models with mTOR hyperactivation frequently, but
not always, exhibit enhanced synaptic transmission and plasticity.
ThemTOR signaling pathway plays a critical role in regulating how
a neuron responds to the network in which it is embedded, and
correspondingly, the impact of disrupting the pathway appears
to exhibit network speciﬁc effects. Moreover, large populations
of PTEN and TSC KO cells have the ability to induce secondary
changes among the networks they inﬂuence, which in turn may
produce tertiary, feedback changes among the KO cells. The com-
plexity of this system creates signiﬁcant hurdles for understanding
the mTOR pathway, and is likely responsible for many of the
paradoxical ﬁndings, but future studies are likely to provide impor-
tant new insights into the acute and chronic effects of disrupted
mTOR signaling in the many diseases in which the path is now
implicated.
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